Aligos Therapeutics Inc.

NASDAQ: ALGS · Real-Time Price · USD
8.10
0.39 (5.06%)
At close: Jun 16, 2025, 3:59 PM
8.05
-0.56%
Pre-market: Jun 17, 2025, 04:53 AM EDT

Aligos Therapeutics Revenue

Aligos Therapeutics reported an annual revenue of $3.94M, reflecting a -74.6% growth. For the quarter ending March 31, 2025, Aligos Therapeutics generated $311K in revenue.
Revenue (ttm)
$3.94M
Revenue Growth
-74.6%
Price / Sales Ratio
63.27
Revenue / Employee
$56.36K
Employees
70
Market Cap
49.5M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.